Sumitomo Dainippon Pharma Co (JP:4506) has released an update.
Sumitomo Pharma Co., Ltd. has reinforced its commitment to effective corporate governance, aiming to enhance healthcare and improve lives through innovation. The company adheres fully to the principles of the Corporate Governance Code, including the evaluation of strategic shareholdings and related party transactions to ensure fairness and corporate value enhancement. Strategic shareholdings have been reduced from 39 in 2015 to 12 by March 2024, reflecting a focus on sustainability and value.
For further insights into JP:4506 stock, check out TipRanks’ Stock Analysis page.
